These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12123283)

  • 1. The promyelocytic leukemia nuclear body: sites of activity?
    Eskiw CH; Bazett-Jones DP
    Biochem Cell Biol; 2002; 80(3):301-10. PubMed ID: 12123283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
    Duprez E; Lillehaug JR; Naoe T; Lanotte M
    Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PML bodies: a meeting place for genomic loci?
    Ching RW; Dellaire G; Eskiw CH; Bazett-Jones DP
    J Cell Sci; 2005 Mar; 118(Pt 5):847-54. PubMed ID: 15731002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling.
    Doucas V; Tini M; Egan DA; Evans RM
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2627-32. PubMed ID: 10077561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body.
    Boisvert FM; Kruhlak MJ; Box AK; Hendzel MJ; Bazett-Jones DP
    J Cell Biol; 2001 Mar; 152(5):1099-106. PubMed ID: 11238464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus.
    Muratani M; Gerlich D; Janicki SM; Gebhard M; Eils R; Spector DL
    Nat Cell Biol; 2002 Feb; 4(2):106-10. PubMed ID: 11753375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells.
    Weis K; Rambaud S; Lavau C; Jansen J; Carvalho T; Carmo-Fonseca M; Lamond A; Dejean A
    Cell; 1994 Jan; 76(2):345-56. PubMed ID: 8293468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus.
    Müller S; Matunis MJ; Dejean A
    EMBO J; 1998 Jan; 17(1):61-70. PubMed ID: 9427741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.
    Grignani F; Testa U; Rogaia D; Ferrucci PF; Samoggia P; Pinto A; Aldinucci D; Gelmetti V; Fagioli M; Alcalay M; Seeler J; Grignani F; Nicoletti I; Peschle C; Pelicci PG
    EMBO J; 1996 Sep; 15(18):4949-58. PubMed ID: 8890168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.
    Bernardi R; Pandolfi PP
    Nat Rev Mol Cell Biol; 2007 Dec; 8(12):1006-16. PubMed ID: 17928811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.
    Tatemichi Y; Shibazaki M; Yasuhira S; Kasai S; Tada H; Oikawa H; Suzuki Y; Takikawa Y; Masuda T; Maesawa C
    Cancer Sci; 2015 Jul; 106(7):848-56. PubMed ID: 25891951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of promyelocytic leukemia (PML)/retinoic acid receptor-alpha and PML expression in acute promyelocytic leukemia cells by anti-PML peptide nucleic acid.
    Mologni L; Marchesi E; Nielsen PE; Gambacorti-Passerini C
    Cancer Res; 2001 Jul; 61(14):5468-73. PubMed ID: 11454693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3.
    Fu C; Ahmed K; Ding H; Ding X; Lan J; Yang Z; Miao Y; Zhu Y; Shi Y; Zhu J; Huang H; Yao X
    Oncogene; 2005 Aug; 24(35):5401-13. PubMed ID: 15940266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.
    Roussigne M; Cayrol C; Clouaire T; Amalric F; Girard JP
    Oncogene; 2003 Apr; 22(16):2432-42. PubMed ID: 12717420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies.
    Koken MH; Reid A; Quignon F; Chelbi-Alix MK; Davies JM; Kabarowski JH; Zhu J; Dong S; Chen S; Chen Z; Tan CC; Licht J; Waxman S; de Thé H; Zelent A
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10255-60. PubMed ID: 9294197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML.
    Borden KL; Lally JM; Martin SR; O'Reilly NJ; Solomon E; Freemont PS
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1601-6. PubMed ID: 8643677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
    Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
    Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.
    Borden KL
    Mol Cell Biol; 2002 Aug; 22(15):5259-69. PubMed ID: 12101223
    [No Abstract]   [Full Text] [Related]  

  • 19. In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodies.
    Giannì M; de Thé H
    Leukemia; 1999 May; 13(5):739-49. PubMed ID: 10374879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role and fate of PML nuclear bodies in response to interferon and viral infections.
    Regad T; Chelbi-Alix MK
    Oncogene; 2001 Oct; 20(49):7274-86. PubMed ID: 11704856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.